Sales rise 14.23% to Rs 2539.86 crore
Net profit of Glenmark Pharmaceuticals rose 93.35% to Rs 414.00 crore in the quarter ended September 2018 as against Rs 214.12 crore during the previous quarter ended September 2017. Sales rose 14.23% to Rs 2539.86 crore in the quarter ended September 2018 as against Rs 2223.44 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales2539.862223.44 14 OPM %17.3317.47 -PBDT494.86348.28 42 PBT412.41273.05 51 NP414.00214.12 93Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content